Cargando…
Structural Hypervariability of the Two Human Protein Kinase CK2 Catalytic Subunit Paralogs Revealed by Complex Structures with a Flavonol- and a Thieno[2,3-d]pyrimidine-Based Inhibitor †
Protein kinase CK2 is associated with a number of human diseases, among them cancer, and is therefore a target for inhibitor development in industry and academia. Six crystal structures of either CK2α, the catalytic subunit of human protein kinase CK2, or its paralog CK2α′ in complex with two ATP-co...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374413/ https://www.ncbi.nlm.nih.gov/pubmed/28085026 http://dx.doi.org/10.3390/ph10010009 |
_version_ | 1782518885220614144 |
---|---|
author | Niefind, Karsten Bischoff, Nils Golub, Andriy G. Bdzhola, Volodymyr G. Balanda, Anatoliy O. Prykhod’ko, Andriy O. Yarmoluk, Sergiy M. |
author_facet | Niefind, Karsten Bischoff, Nils Golub, Andriy G. Bdzhola, Volodymyr G. Balanda, Anatoliy O. Prykhod’ko, Andriy O. Yarmoluk, Sergiy M. |
author_sort | Niefind, Karsten |
collection | PubMed |
description | Protein kinase CK2 is associated with a number of human diseases, among them cancer, and is therefore a target for inhibitor development in industry and academia. Six crystal structures of either CK2α, the catalytic subunit of human protein kinase CK2, or its paralog CK2α′ in complex with two ATP-competitive inhibitors—based on either a flavonol or a thieno[2,3-d]pyrimidine framework—are presented. The structures show examples for extreme structural deformations of the ATP-binding loop and its neighbourhood and of the hinge/helix αD region, i.e., of two zones of the broader ATP site environment. Thus, they supplement our picture of the conformational space available for CK2α and CK2α′. Further, they document the potential of synthetic ligands to trap unusual conformations of the enzymes and allow to envision a new generation of inhibitors that stabilize such conformations. |
format | Online Article Text |
id | pubmed-5374413 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-53744132017-04-10 Structural Hypervariability of the Two Human Protein Kinase CK2 Catalytic Subunit Paralogs Revealed by Complex Structures with a Flavonol- and a Thieno[2,3-d]pyrimidine-Based Inhibitor † Niefind, Karsten Bischoff, Nils Golub, Andriy G. Bdzhola, Volodymyr G. Balanda, Anatoliy O. Prykhod’ko, Andriy O. Yarmoluk, Sergiy M. Pharmaceuticals (Basel) Article Protein kinase CK2 is associated with a number of human diseases, among them cancer, and is therefore a target for inhibitor development in industry and academia. Six crystal structures of either CK2α, the catalytic subunit of human protein kinase CK2, or its paralog CK2α′ in complex with two ATP-competitive inhibitors—based on either a flavonol or a thieno[2,3-d]pyrimidine framework—are presented. The structures show examples for extreme structural deformations of the ATP-binding loop and its neighbourhood and of the hinge/helix αD region, i.e., of two zones of the broader ATP site environment. Thus, they supplement our picture of the conformational space available for CK2α and CK2α′. Further, they document the potential of synthetic ligands to trap unusual conformations of the enzymes and allow to envision a new generation of inhibitors that stabilize such conformations. MDPI 2017-01-11 /pmc/articles/PMC5374413/ /pubmed/28085026 http://dx.doi.org/10.3390/ph10010009 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Niefind, Karsten Bischoff, Nils Golub, Andriy G. Bdzhola, Volodymyr G. Balanda, Anatoliy O. Prykhod’ko, Andriy O. Yarmoluk, Sergiy M. Structural Hypervariability of the Two Human Protein Kinase CK2 Catalytic Subunit Paralogs Revealed by Complex Structures with a Flavonol- and a Thieno[2,3-d]pyrimidine-Based Inhibitor † |
title | Structural Hypervariability of the Two Human Protein Kinase CK2 Catalytic Subunit Paralogs Revealed by Complex Structures with a Flavonol- and a Thieno[2,3-d]pyrimidine-Based Inhibitor † |
title_full | Structural Hypervariability of the Two Human Protein Kinase CK2 Catalytic Subunit Paralogs Revealed by Complex Structures with a Flavonol- and a Thieno[2,3-d]pyrimidine-Based Inhibitor † |
title_fullStr | Structural Hypervariability of the Two Human Protein Kinase CK2 Catalytic Subunit Paralogs Revealed by Complex Structures with a Flavonol- and a Thieno[2,3-d]pyrimidine-Based Inhibitor † |
title_full_unstemmed | Structural Hypervariability of the Two Human Protein Kinase CK2 Catalytic Subunit Paralogs Revealed by Complex Structures with a Flavonol- and a Thieno[2,3-d]pyrimidine-Based Inhibitor † |
title_short | Structural Hypervariability of the Two Human Protein Kinase CK2 Catalytic Subunit Paralogs Revealed by Complex Structures with a Flavonol- and a Thieno[2,3-d]pyrimidine-Based Inhibitor † |
title_sort | structural hypervariability of the two human protein kinase ck2 catalytic subunit paralogs revealed by complex structures with a flavonol- and a thieno[2,3-d]pyrimidine-based inhibitor † |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374413/ https://www.ncbi.nlm.nih.gov/pubmed/28085026 http://dx.doi.org/10.3390/ph10010009 |
work_keys_str_mv | AT niefindkarsten structuralhypervariabilityofthetwohumanproteinkinaseck2catalyticsubunitparalogsrevealedbycomplexstructureswithaflavonolandathieno23dpyrimidinebasedinhibitor AT bischoffnils structuralhypervariabilityofthetwohumanproteinkinaseck2catalyticsubunitparalogsrevealedbycomplexstructureswithaflavonolandathieno23dpyrimidinebasedinhibitor AT golubandriyg structuralhypervariabilityofthetwohumanproteinkinaseck2catalyticsubunitparalogsrevealedbycomplexstructureswithaflavonolandathieno23dpyrimidinebasedinhibitor AT bdzholavolodymyrg structuralhypervariabilityofthetwohumanproteinkinaseck2catalyticsubunitparalogsrevealedbycomplexstructureswithaflavonolandathieno23dpyrimidinebasedinhibitor AT balandaanatoliyo structuralhypervariabilityofthetwohumanproteinkinaseck2catalyticsubunitparalogsrevealedbycomplexstructureswithaflavonolandathieno23dpyrimidinebasedinhibitor AT prykhodkoandriyo structuralhypervariabilityofthetwohumanproteinkinaseck2catalyticsubunitparalogsrevealedbycomplexstructureswithaflavonolandathieno23dpyrimidinebasedinhibitor AT yarmoluksergiym structuralhypervariabilityofthetwohumanproteinkinaseck2catalyticsubunitparalogsrevealedbycomplexstructureswithaflavonolandathieno23dpyrimidinebasedinhibitor |